Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents	$ 13,317,581	$ 4,465,455
Accounts receivable, net	308,523	424,287
Inventories, net	759,803	439,533
Prepaid expenses and other	790,290	820,206
Total Current Assets	15,176,197	6,149,481
Restricted cash	75,000	75,000
Deferred offering costs		219,240
Equipment, net	105,589	154,972
Total Assets	15,356,786	6,598,693
Current Liabilities:
Convertible note payable, net of discount of $553 and $676,703 at September 30, 2020 and December 31, 2019, respectively	78,045	1,763,887
Accounts payable and accrued expenses	2,122,140	1,738,490
Derivative liabilities		378,239
Deferred revenue	6,684	2,913
Total Current Liabilities	2,206,869	3,883,529
Long-term debt, net of discount of $36,169 at December 31, 2019		888,961
Other long-term liabilities	165,889
Deferred revenue	1,495	1,495
Total Liabilities	2,374,253	4,773,985
Commitments and Contingencies
Stockholders’ Equity:
Common stock par value $0.0001 per share, 100,000,000 shares authorized; 4,561,469 and 574,524 shares issued as of September 30, 2020 and December 31, 2019, respectively; and 4,561,442 and 574,497 shares outstanding at September 30, 2020 and December 31, 2019, respectively	456	57
Additional paid-in capital	78,980,021	57,957,097
Accumulated deficit	(65,991,480)	(56,125,982)
Treasury stock, 27 shares at cost	(6,464)	(6,464)
Total Stockholders’ Equity	12,982,533	1,824,708
Total Liabilities and Stockholders’ Equity	$ 15,356,786	$ 6,598,693